Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 3
1967 1
1968 4
1969 2
1970 5
1971 4
1972 2
1973 3
1974 6
1975 5
1976 2
1977 5
1978 15
1979 14
1980 15
1981 15
1982 11
1983 10
1984 22
1985 10
1986 15
1987 12
1988 14
1989 13
1990 14
1991 16
1992 12
1993 14
1994 13
1995 8
1996 8
1997 7
1998 10
1999 17
2000 6
2001 15
2002 9
2003 8
2004 9
2005 9
2006 11
2007 9
2008 13
2009 6
2010 17
2011 13
2012 23
2013 35
2014 36
2015 32
2016 44
2017 53
2018 63
2019 47
2020 35
2021 26
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

796 results
Results by year
Filters applied: . Clear all
Page 1
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.
Yamaya M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K, Shimotai Y, Momma H, Ichinose M, Kawase T. Yamaya M, et al. Respir Investig. 2020 May;58(3):155-168. doi: 10.1016/j.resinv.2019.12.005. Epub 2020 Feb 21. Respir Investig. 2020. PMID: 32094077 Free PMC article.
Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis.
Nwannunu CE, Limmer AL, Coleman K, Shah R, Patel RR, Mui UN, Tyring SK. Nwannunu CE, et al. Skin Therapy Lett. 2019 Mar;24(2):1-3. Skin Therapy Lett. 2019. PMID: 30970203 Free article. Review.
▾Glycopyrronium for COPD.
[No authors listed] [No authors listed] Drug Ther Bull. 2013 Jun;51(6):66-8. doi: 10.1136/dtb.2013.6.0184. Epub 2013 Jun 6. Drug Ther Bull. 2013. PMID: 23744364 Review.
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Reisner C, Dorinsky P. Rabe KF, et al. Respir Med. 2019 Oct-Nov;158:59-66. doi: 10.1016/j.rmed.2019.08.010. Epub 2019 Aug 22. Respir Med. 2019. PMID: 31605923 Free article. Clinical Trial.
Topical glycopyrronium in Darier's disease.
Stravodimou A, Markantoni V, Platsidaki E, Agiasofitou E, Rigopoulos D, Kontochristopoulos G. Stravodimou A, et al. Dermatol Ther. 2019 Nov;32(6):e13114. doi: 10.1111/dth.13114. Epub 2019 Oct 24. Dermatol Ther. 2019. PMID: 31595666 No abstract available.
796 results